Technical analysis of The Cooper Companies, Inc. (COO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses.
Price Performance
| 1 month | +4.64% |
| 3 months | -20.27% |
| Year-to-date | -27.34% |
| 1 year | -14.82% |
| 3 years | -28.82% |
| 5 years | -43.62% |
| 10 years | +35.46% |
52-Week Range
| 52-week High | $89.83 |
| 52-week Low | $51.01 |
| Avg Volume (90d) | 3.1M |
Technical Indicators
| SMA 50 | $60.33 |
| SMA 200 | $68.90 |
| Beta | 1.07 |
| 30-day Volatility (annualised) | 27.5% |
| Price vs SMA 50 | -1.3% |
| Price vs SMA 200 | -13.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $81.96 | |
| 2026-01 | $81.38 | -0.7% |
| 2026-02 | $83.67 | +2.8% |
| 2026-03 | $71.50 | -14.5% |
| 2026-04 | $62.90 | -12.0% |
| 2026-05 | $61.21 | -2.7% |
| 2026-06 | $71.71 | +17.2% |
| 2026-07 | $72.32 | +0.9% |
| 2026-08 | $70.09 | -3.1% |
| 2026-09 | $56.53 | -19.3% |
| 2026-10 | $59.55 | +5.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-12-03 | $1.07 | $1.07B |
| 2026-09-09 | $1.12 | $1.10B |
| 2026-06-04 | $1.10 | $1.05B |
| 2026-03-05 | $1.03 | $1.02B |
| 2025-12-04 | $1.11 | $1.06B |
| 2025-08-27 | $1.07 | $1.06B |
| 2025-05-29 | $0.93 | $995M |
Price
| Price | $59.55 (closing price, October 30, 2026) |
| Market Cap | $11.3B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 20.32 |
| Price / Book | 1.38 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.31 |
| Current Ratio | 1.22 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 3.49 |